Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04610528 |
Title | A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression (TOT-HER3) |
Acronym | TOT-HER3 |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | SOLTI Breast Cancer Research Group |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
ICO Badalona | Badalona | Barcelona | Spain | Details | ||
Institut Català d'Oncologia Hospitalet | Hospitalet de Llobregat | Barcelona | Spain | Details | ||
Hospital Universitario de Canarias | Tenerife | Islas Canarias | 38320 | Spain | Details | |
Hospital Universitario de Fuenlabrada | Fuenlabrada | Madrid | Spain | Details | ||
Hospital Universitari Vall d'Hebrón | Barcelona | 08035 | Spain | Details | ||
Hospital Clínic de Barcelona | Barcelona | 08036 | Spain | Details | ||
Centro Integral Oncológico Clara Campal (CIOCC) | Madrid | Spain | Details | |||
Hospital Universitario 12 de Octubre | Madrid | Spain | Details | |||
Hospital Universitario Virgen del Rocio | Sevilla | Spain | Details | |||
Hospital Clinico Universitario de Valencia | Valencia | Spain | Details |